Nausea Gravidarum
10
0
0
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
10.0%
1 terminated out of 10 trials
87.5%
+1.0% vs benchmark
0%
0 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (10)
Ottawa Nutritional Guidelines for Nausea and Vomiting
Tablet Ginger Versus Tablet Doxylamine Succinate in Control of Nausea and Vomiting in Pregnancy
The Effect of Plaster on Nausea-Vomiting During Pregnancy
Chewing Gum Containing Vitamin-c to Treat Emesis Gravidarum
Anxiety in Relation to Nausea and Vomiting in Pregnancy
Capsaicin Cream as an Adjunctive Therapy for Nausea and Vomiting of Pregnancy
Emotional Freedom Technique in Early Pregnancy
A Study of the Effect of Probiotics on Gastrointestinal Function During Pregnancy
Validating the Effect og Ondansetron and Mirtazapine in Treating Hyperemesis Gravidarum
Prevalence And Burden Of Nausea And Vomiting In Pregnant Women